Respiratory Health and Sleep Apnea Flashcards

A commercial driver with a BMI of 31 kg/m² presents for a DOT physical. He reports no witnessed apneas and denies excessive daytime sleepiness, but his Epworth Sleepiness Scale score is 9. His neck circumference is 17.5 inches. Which finding, if also present, would most significantly elevate his pre-test probability for obstructive sleep apnea using the STOP-BANG criteria?

Answer: Loud snoring reported by a bed partner

The STOP-BANG tool scores Snoring, Tiredness, Observed apnea, Pressure (hypertension), BMI >35, Age >50, Neck >40 cm, and Gender (male). This driver already scores points for BMI >30 (close, but the threshold is >35 for STOP-BANG) and male gender. Loud snoring (S) is a direct, high-weight criterion in STOP-BANG, immediately adding a point and raising his score. Treated hypertension (P) would also add a point, but the question asks for the *most significant* single elevating factor — snoring is both more directly diagnostic of OSA physiology and a primary STOP-BANG item, whereas the hypertension criterion is already partially met. Fasting glucose of 105 mg/dL is not a STOP-BANG criterion, and age 48 does not meet the >50 threshold.

A driver certified with moderate OSA is being managed with auto-titrating positive airway pressure (APAP). His compliance download shows average nightly use of 5.8 hours over the past 90 days, a residual AHI of 3.2 events/hour, and a leak rate at the 95th percentile of 38 L/min. He denies residual sleepiness. Under FMCSA guidance, which aspect of this download should prompt the most concern regarding continued certification?

Answer: The 95th-percentile leak rate of 38 L/min may indicate ineffective therapy despite reported adherence

A 95th-percentile leak rate of 38 L/min is significantly elevated (most guidelines flag >24 L/min as a large leak threshold). High leak rates cause pressure instability and reduce therapeutic efficacy, meaning the residual AHI may be artificially low and therapy may not be adequately controlling apneas during high-leak periods — the driver could be experiencing uncorrected obstruction. The residual AHI of 3.2 is within acceptable treated range (<5). FMCSA does not mandate a 7-hour minimum use; it requires effective, consistent use (typically ≥4 hours on ≥70% of nights as a proxy). APAP is an accepted treatment modality for OSA in commercial drivers.

An examiner is evaluating a 55-year-old driver with a prior history of lung cancer treated with right upper lobe lobectomy 3 years ago. He is currently in complete remission confirmed by oncology. Spirometry shows FEV1 of 62% predicted, FVC of 78% predicted, and FEV1/FVC ratio of 0.72. He is asymptomatic at rest and with mild exertion. What is the most appropriate certification decision?

Answer: Refer to a respiratory specialist and defer certification until an exercise tolerance test confirms no exertional oxygen desaturation

FMCSA regulations (49 CFR 391.41(b)(5)) require that a driver not have a current clinical diagnosis of a respiratory dysfunction likely to interfere with safe vehicle control. An FEV1 of 62% predicted represents moderate obstruction (GOLD Stage II), and the post-lobectomy anatomy means baseline reserve is reduced. While remission status is favorable, exertional oxygen desaturation is a key safety concern in this population. An exercise tolerance test (e.g., 6-minute walk with oximetry, or formal cardiopulmonary exercise testing) objectively confirms whether desaturation occurs under conditions relevant to driving demands. Permanent disqualification based on prior malignancy alone is not FMCSA policy. Annual spirometry without functional testing does not adequately address the safety question. Certifying without objective exertional data is premature given the moderate obstruction.

A driver is referred for a DOT physical after his employer noticed microsleep episodes during long hauls. Overnight polysomnography reveals an AHI of 22 events/hour with a minimum oxygen saturation of 81% and 14% of total sleep time below 90% SpO2. He is started on CPAP. After 8 weeks of CPAP use, a compliance report shows AHI of 1.8 events/hour and average use of 6.2 hours/night, but his Epworth score remains 14. What is the most likely explanation and appropriate next step?

Answer: Persistent sleepiness despite effective CPAP may indicate a comorbid condition such as narcolepsy or idiopathic hypersomnia; further sleep medicine evaluation is required before certification

When CPAP effectively controls OSA (residual AHI 10 is not normal even in shift workers for certification purposes.

Under 49 CFR 391.41(b)(5), which of the following clinical scenarios represents the most defensible basis for granting a one-year medical certificate rather than the full two-year certificate to a commercial driver with sleep apnea?

Answer: A driver with severe OSA (AHI 48) who has been adherent to CPAP for 6 months, with residual AHI of 2.1 and ESS of 6

A driver with severe OSA (AHI 48) who has achieved excellent CPAP response has demonstrated efficacy, but the duration of 6 months is relatively short, and severe baseline OSA carries higher consequences if treatment is interrupted or becomes ineffective. A shortened certificate interval (one year vs. two) allows more frequent verification of continued adherence and effectiveness, which is clinically and medicolegally prudent. The driver with mild OSA who achieved disease resolution via weight loss and documented AHI of 3.5 can be considered for full two-year certification given objective remission. Minor compliance gaps (3 nights missed out of 90) do not alone mandate a shortened interval if overall pattern is adequate. Positional therapy with self-reported compliance has no objective verification mechanism, but the underlying mild severity is a mitigating factor.

A truck driver presents with a PSG report showing an AHI of 5.8 events/hour, classified as mild OSA by the interpreting physician. However, the report also notes a respiratory disturbance index (RDI) of 24 events/hour and 22% of total sleep time with SpO2 below 90%. The driver denies sleepiness (ESS 7). How should the NRCME examiner interpret this discrepancy and what action is most appropriate?

Answer: Recognize that the RDI captures respiratory effort-related arousals excluded from AHI; the high RDI and significant hypoxemia suggest clinically significant sleep-disordered breathing warranting treatment before certification

The AHI counts only apneas and hypopneas meeting strict amplitude/desaturation thresholds, while the RDI additionally includes respiratory effort-related arousals (RERAs) — brief arousals from partial upper airway obstruction that fragment sleep without meeting apnea/hypopnea criteria. An RDI of 24 with 22% of sleep below 90% SpO2 indicates substantial sleep fragmentation and nocturnal hypoxemia that the AHI alone understates. This pattern is associated with daytime impairment, cardiovascular risk, and crash risk even when AHI is classified as 'mild.' FMCSA's underlying standard is any 'respiratory dysfunction likely to interfere with safe driving' — not a strict AHI cutoff. Certification without treatment given significant hypoxemia and high RDI would not meet that standard. Home sleep testing would undercount RERAs even further (it cannot detect arousals). Immediate disqualification without treatment pathway is overly punitive and not the required approach.